Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 16:11:1506847.
doi: 10.3389/fnut.2024.1506847. eCollection 2024.

Coffee and tea consumption and glioma risk: a meta-analysis of cohort studies

Affiliations

Coffee and tea consumption and glioma risk: a meta-analysis of cohort studies

Jinyu Pan et al. Front Nutr. .

Abstract

Background: Research on the association between glioma risk and coffee and tea consumption remains inconclusive. This study seeks to present a meta-analysis of the relationship between coffee and tea intake and glioma risk.

Method: Relevant cohort studies that collected coffee and tea exposure prospectively were identified through searches of the PubMed, Embase, and Scopus databases. Eligible studies included those providing adjusted relative risk estimates or hazard ratios (HRs) with 95% confidence intervals (CIs), or data sufficient for such calculations. Study quality was evaluated using the Newcastle-Ottawa Scale, while the GRADE system assessed the quality of evidence. The analysis explored glioma risk concerning the highest versus lowest levels of coffee and tea intake, supplemented by a dose-response evaluation using a one-stage robust error meta-regression model.

Results: A total of nine studies, published between 2004 and 2020, were included. In a model comparing the highest and lowest levels of coffee and tea consumption, 3,896 glioma cases were identified among 2,648,468 participants. Correspondingly, the pooled HRs with 95% CIs were 0.98 (0.87-1.09) for coffee and 0.95 (0.86-1.06) for tea, respectively. Furthermore, no evidence of publication bias was detected for either beverage. The dose-response analysis indicated a near "L"-shaped relationship between tea consumption and glioma risk, with the most notable risk reduction observed in individuals consuming more than 2.5 cups of tea per day. However, additional tea intake beyond this threshold did not confer evident risk reduction. According to Grade scoring system, the quality of meta-evidence was classified as "very low" for coffee and "low" for tea.

Conclusion: This meta-analysis provides evidence suggesting a potential inverse association between tea consumption and glioma risk, while no such association was observed for coffee consumption. Given that the evidence for coffee was classified as "very low" and for tea as "low," cautious interpretation of the findings is warranted, and further research is needed to validate these results.

Keywords: coffee; cohort; glioma; meta-analysis; risk factors; tea.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of identifying studies.
Figure 2
Figure 2
Forest plots for the relationship between coffee and tea intake and glioma risk.
Figure 3
Figure 3
Funnel plot for publication bias. (A) Coffee; (B) tea.
Figure 4
Figure 4
Dose–response relationship. (A) Coffee; (B) tea.

Similar articles

References

    1. Weller M, Wen PY, Chang SM, Dirven L, Lim M, Monje M, et al. . Glioma. Nat Rev Dis Primers. (2024) 10:33. doi: 10.1038/s41572-024-00516-y - DOI - PubMed
    1. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. . The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncology. (2021) 23:1231–51. doi: 10.1093/neuonc/noab106, PMID: - DOI - PMC - PubMed
    1. Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. (2023) 329:574–87. doi: 10.1001/jama.2023.0023, PMID: - DOI - PMC - PubMed
    1. Lin D, Wang M, Chen Y, Gong J, Chen L, Shi X, et al. . Trends in intracranial glioma incidence and mortality in the United States, 1975-2018. Front Oncol. (2021) 11:748061. doi: 10.3389/fonc.2021.748061 - DOI - PMC - PubMed
    1. Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol. (2018) 4:1254–62. doi: 10.1001/jamaoncol.2018.1789, PMID: - DOI - PMC - PubMed

Publication types

LinkOut - more resources